Literature DB >> 1381320

Characterization of Chilean, Bolivian, and Argentinian Trypanosoma cruzi populations by restriction endonuclease and isoenzyme analysis.

A Solari1, S Muñoz, J Venegas, A Wallace, X Aguilera, W Apt, S F Brenière, M Tibayrenc.   

Abstract

Ninety-one Chilean, 15 Bolivian, and 9 Argentinian Trypanosoma cruzi stocks, isolated from various hosts and vectors, were characterized by schizodeme analysis with EcoRI and MspI endonucleases. The three major similar pattern groups that emerged from this sample correlated with results of isoenzyme analysis. This result confirms previous work and supports the hypothesis of the clonal structure of natural populations of T. cruzi, fully defined at the level of isoenzyme analysis, quantitative kinetoplast DNA restriction fragment length polymorphism, and kinetoplast DNA hybridization analysis. In Chile, sylvatic and domestic cycles of T. cruzi transmission appear to be mainly independent: genetically different families of natural clones are specific to these cycles. Nevertheless, the possibility of overlap remains unclear. Results described here indicate that natural clones inhabiting Chilean regions appear genetically related to the natural clones identified in neighboring countries. In Chile the more frequently sampled parasite types are natural clone 39 and a genetically closely related clone NP13. In this work an evaluation of T. cruzi natural clone mixtures in T. cruzi stocks from Chile was performed for the first time by schizodeme analysis before and after serial transfer in mouse maintenance. The results indicate that six of nine stocks are composed of two or more natural clones. This observation raises the relevant question of whether specific T. cruzi natural clones generate different clinical features of Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381320     DOI: 10.1016/0014-4894(92)90178-d

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  4 in total

1.  Predominance of Trypanosoma cruzi lineage I in Mexico.

Authors:  Marie-France Bosseno; Christian Barnabé; Ezequiel Magallón Gastélum; Felipe Lozano Kasten; Janine Ramsey; Bertha Espinoza; Simone Frédérique Brenière
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

Review 2.  Current and developing therapeutic agents in the treatment of Chagas disease.

Authors:  Werner Apt
Journal:  Drug Des Devel Ther       Date:  2010-09-24       Impact factor: 4.162

3.  Elucidating diversity in the class composition of the minicircle hypervariable region of Trypanosoma cruzi: New perspectives on typing and kDNA inheritance.

Authors:  Fanny Rusman; Nicolás Tomasini; Noelia-Floridia Yapur; Andrea F Puebla; Paula G Ragone; Patricio Diosque
Journal:  PLoS Negl Trop Dis       Date:  2019-06-27

4.  Trypanosoma cruzi Discret Typing Units (TcII and TcVI) in samples of patients from two municipalities of the Jequitinhonha Valley, MG, Brazil, using two molecular typing strategies.

Authors:  Maykon Tavares de Oliveira; Girley Francisco Machado de Assis; Jaquelline Carla Valamiel Oliveira e Silva; Evandro Marques Menezes Machado; Glenda Nicioli da Silva; Vanja Maria Veloso; Andrea Mara Macedo; Helen Rodrigues Martins; Marta de Lana
Journal:  Parasit Vectors       Date:  2015-10-31       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.